Top

BMC Medicine

Published in:

Open Access 01-12-2020 | COVID-19 | Research article

Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January–February, 2020

Authors: Kenji Mizumoto, Katsushi Kagaya, Gerardo Chowell

Published in: BMC Medicine | Issue 1/2020

Abstract

Background

Since the first cluster of cases was identified in Wuhan City, China, in December 2019, coronavirus disease 2019 (COVID-19) rapidly spreads globally. Scientists have made strides in estimating key transmission and epidemiological parameters. In particular, accumulating evidence points to a substantial fraction of asymptomatic or subclinical infections, which influences our understanding of the transmission potential and severity of this emerging disease. In this study, we derive estimates of the transmissibility and virulence of COVID-19 in Wuhan City, China, by reconstructing the underlying transmission dynamics using multiple data sources.

Methods

We employ statistical methods and publicly available epidemiological datasets to jointly derive estimates of transmissibility and severity associated with the novel coronavirus. For this purpose, the daily series of laboratory-confirmed COVID-19 cases and deaths in Wuhan City together with epidemiological data of Japanese repatriated from Wuhan City on board government-chartered flights were integrated into our analysis.

Results

Our posterior estimates of basic reproduction number (R) in Wuhan City, China, in 2019–2020 reached values at 3.49 (95% CrI 3.39–3.62) with a mean serial interval of 6.0 days, and the enhanced public health intervention after January 23 in 2020 was associated with a significantly reduced R at 0.84 (95% CrI 0.81–0.88), with the total number of infections (i.e., cumulative infections) estimated at 1,906,634 (95% CrI 1,373,500–2,651,124) in Wuhan City, elevating the overall proportion of infected individuals to 19.1% (95% CrI 13.5–26.6%). We also estimated the most recent crude infection fatality ratio (IFR) and time–delay adjusted IFR at 0.04% (95% CrI 0.03–0.06%) and 0.12% (95% CrI 0.08–0.17%), respectively, estimates that are substantially smaller than the crude CFR estimated at 4.06%.

Conclusions

We have estimated key epidemiological parameters of the transmissibility and virulence of COVID-19 in Wuhan, China, during January–February 2020 using an ecological modeling approach that is suitable to infer epidemiological parameters with quantified uncertainty from partial observations collected by surveillance systems. Our estimate of time–delay adjusted IFR falls in the range of the median IFR estimates based on multiple serological studies conducted in several areas of the world.

Available only for authorised users

Jon Cohen. Mining coronavirus genomes for clues to the outbreak’s origins. Science. 2020. https://www.sciencemag.org/news/2020/01/mining-coronavirus-genomes-clues-outbreak-s-origins. Accessed 3 Feb 2020.

World Health Organization (WHO). Novel coronavirus (2019-nCoV) situation reports. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports Accessed, [cited 2020 May 10^th ].

The State Council, The People’s Republic of China. http://www.gov.cn/. [cited 2020 May 10^th ].

Nishiura H, Jung SM, Linton NM, Kinoshita R, Yang Y, Hayashi K, et al. The extent of transmission of novel coronavirus in Wuhan, China, 2020. J Clin Med. 2020;9(2):330.CrossRef

Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020. https://doi.org/10.1016/s0140-6736(20)30260-9.

Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, Yuan B, Kinoshita R, Nishiura H. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(2):538.

Health Commission of Hubei Province, China. http://wjw.hubei.gov.cn/. [cited 2020 Feb 7^th].

Health Commission of Wuhan City, Hubei Province, China http://wjw.hubei.gov.cn/. [cited 2020 Feb 7 ^th].

Clinical guideline for COVID-19, version 5. The State Council, The People’s Republic of China. Available from http://www.gov.cn/zhengce/zhengceku/2020-02/05/5474791/files/de44557832ad4be1929091dcbcfca891.pdf. Accessed 29 Feb 2020. [in Chinese].

10.

Ministry of Health, Labour and Welfare, Japan. https://www.mhlw.go.jp/index.html [in Japanese]. Accessed 7 Feb 2020.

11.

2020 Hubei lockdowns, Wikipedia. https://en.wikipedia.org/wiki/2020_Hubei_lockdowns. Accessed 7 Feb 2020.

12.

Li R, Weiskittel AR, Kershaw Jr JA. Modeling annualized occurrence, frequency, and composition of ingrowth using mixed-effects zero-inflated models and permanent plots in the Acadian Forest Region of North America. Can J For Res. 2011;41:2077–89.CrossRef

13.

Northeastern University. Laboratory for the modeling of biological and socio-technical systems, 2020. Available online: https://www.mobs-lab.org/2019ncov.html. Accessed 22 Jan , 2020.

14.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382:1199–207. https://doi.org/10.1056/NEJMoa2001316. Available at: https://www.nejm.org/doi/full/10.1056/NEJMoa2001316.

15.

Nishiura H, Linton NM, Akhmetzhanov AR. Int J Infect Dis. 2020;93:284–6. https://doi.org/10.1016/j.ijid.2020.02.060.CrossRefPubMedPubMedCentral

16.

Ghani AC, Donnelly CA, Cox DR, Griffin JT, Fraser C, Lam TH, et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. Am J Epidemiol. 2005;162:479–86.CrossRef

17.

Nishiura H, Klinkenberg D, Roberts M, Heesterbeek JA. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS One. 2009;4(8):e6852. https://doi.org/10.1371/journal.pone.0006852.CrossRefPubMedPubMedCentral

18.

Tsuzuki S, Lee H, Miura F, Chan YH, Jung SM, Akhmetzhanov AR, Nishiura H. Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017. Euro Surveill. 2017;22(46). https://doi.org/10.2807/1560-7917.ES.2017.22.46.17-00710.

19.

Mizumoto K, Chowell G. Estimating the risk of 2019 novel coronavirus death during the course of the outbreak in China, 2020. Emerg Infect Dis. 2020;26(6):1251–6.

20.

Gamerman, D. & Lopes, H. F. Markov Chain Monte Carlo: stochastic simulation for Bayesian interference. 2nd edn. London: CRC Press (Chapman & Hall); 2006.

21.

Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;7:457–72. https://doi.org/10.1214/ss/1177011136.CrossRef

22.

Read JM, Bridgen JRE, Cummings DAT, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv. https://doi.org/10.1101/2020.01.23.20018549.

23.

Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S, Ferguson NM. Report 3: transmissibility of 2019-nCoV. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-2019-nCoV-transmissibility.pdf. Accessed 12 Mar 2020.

24.

Mizumoto K, Chowell G. Transmission potential of the novel coronavirus (COVID-19) onboard the Diamond Princess Cruises Ship, 2020. Infect Dis Model. 2020;5:264–70.

25.

Tariq A, Lee Y, Roosa K, Blumberg S, Yan P, Ma S, Chowell G. Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020. BMC Med. 2020;18(1):166. https://doi.org/10.1186/s12916-020-01615-9.

26.

Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis. 2020;93:339–44.

27.

Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, Viboud C. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015;13:210. https://doi.org/10.1186/s12916-015-0450-0.CrossRefPubMedPubMedCentral

28.

Abdirizak F, Lewis R, Chowell G. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting. Theor Biol Med Model. 2019;16(1):16. https://doi.org/10.1186/s12976-019-0112-6.CrossRefPubMedPubMedCentral

29.

Blake Essig, Brent Swails, Yoko Wakatsuki and Ben Westcott, CNN. Top Japanese government adviser says Diamond Princess quarantine was flawed. Updated 0708 GMT (1508 HKT) February 27, 2020. https://edition.cnn.com/2020/02/27/asia/japan-diamond-princess-quarantine-crew-intl-hnk/index.html. Accessed 12 Mar 2020.

30.

Da-hae P, Dam-eun S, Jae-gu K. HANKYOREH. The reasons why transmission is so prevalent among Shincheonji members. Mar 2, 2020. http://english.hani.co.kr/arti/english_edition/e_national/930749.html. Accessed 10 Mar 2020.

31.

Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of 2019 novel coronavirus onboard the Princess Cruises Ship, 2020. Euro Surveill. 2020;25(10):2000180.

32.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–77.

33.

Russell TW, Hellewell J, Jarvis CI, et al. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess Cruise Ship, February 2020. Euro Surveill. 2020;25(12):2000256. https://doi.org/10.2807/1560-7917.ES.2020.25.12.2000256.CrossRefPubMedCentral

34.

Ioannidis J. The infection fatality rate of COVID-19 inferred from seroprevalence data. medRxiv 2020.05.13.20101253.

35.

KKW T, Cheng VCC, Cai JP, Chan KH, Chen LL, Wong LH, et al. Lancet Microbe. https://doi.org/10.1016/S2666-5247(20)30053-7.

36.

Wu X, Fu B, Chen L, Feng Y. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. J Med Virol. https://doi.org/10.1002/jmv.25904.

37.

Giugliano F. Mass coronavirus antibody tests have serious limits. Bloomberg Opin. 2020. Accessed 30 May 2020.

38.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. https://doi.org/10.1001/jama.2020.1585.

39.

Mizumoto K, Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H. Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med. 2015;13:228. https://doi.org/10.1186/s12916-015-0468-3.CrossRefPubMedPubMedCentral

40.

Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H. Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis. 2015;39:7–9. https://doi.org/10.1016/j.ijid.2015.08.005.CrossRefPubMedPubMedCentral

41.

Wong JY, Wu P, Nishiura H, Goldstein E, Lau EH, Yang L, et al. Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol. 2013;177(8):834–40.CrossRef

42.

Presanis AM, De Angelis D, New York City Swine Flu Investigation Team, Hagy A, Reed C, Riley S, Cooper BS, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009;6(12):e1000207.CrossRef

43.

The Guardian. Black people four times more likely to die from Covid-19, ONS finds https://www.theguardian.com/world/2020/may/07/black-people-four-times-more-likely-to-die-from-covid-19-ons-finds. Accessed 29 May 2020.

44.

Mizumoto K, Dahal S, Chowell G. Spatial variability in the risk of death from COVID-19 in 20 regions of Italy. Int J Tuberc Lung. 2020; in press.

45.

Shim E, Mizumoto K, Choi W, et al. Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February–May, 2020. J Clin Med. 2020;9(6):E1641.CrossRef

46.

Dahal S, Mizumoto K, Chowell G. Investigating spatial variability in COVID-19 pandemic severity across 19 geographic areas, Spain, 2020. medRxiv. 2020.04.14.20065524.

47.

Undurraga EA, Chowell G, Mizumoto K. Case fatality risk by age from COVID-19 in a high testing setting in Latin America: Chile, March–May, 2020. medRxiv. 2020.05.25.20112904.

48.

Munayco C, Chowell G, Tariq A, Undurraga EA, Mizumoto K. Risk of death by age and gender from CoVID-19 in Peru, March–May, 2020. medRxiv. 2020.06.14.20123315.

Title: Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January–February, 2020
Authors: Kenji Mizumoto
Katsushi Kagaya
Gerardo Chowell
Publication date: 01-12-2020
Publisher: BioMed Central
Keyword: COVID-19
Published in: BMC Medicine / Issue 1/2020
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-020-01691-x

At a glance: The STEP trials

Springer Medicine

Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January–February, 2020

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Relationship between serum B12 concentrations and mortality: experience in NHANES

Mental health and smoking cessation—a population survey in England

The use and drawbacks of risk-grouping in prediction models

Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach

The three numbers you need to know about healthcare: the 60-30-10 Challenge

Association between Neu5Gc carbohydrate and serum antibodies against it provides the molecular link to cancer: French NutriNet-Santé study